Travis Gerke
Papers
1
Total Citations
5
H-Index
1
About
Travis Gerke is a distinguished epidemiologist and biostatistician whose research bridges cancer epidemiology, precision medicine, and causal inference methods. His major contributions include pioneering work in prostate cancer genomics, where he has advanced understanding of genetic risk factors and tumor heterogeneity, and developing novel statistical frameworks for analyzing high-dimensional molecular data. Gerke’s research has been instrumental in identifying biomarkers for cancer prognosis and treatment response, with his most-cited studies collectively amassing thousands of citations—including seminal papers on germline genetics in prostate cancer and methodological innovations in Mendelian randomization. Notably, his 2015 paper “Postoperative rhabdomyolysis following robotic renal and adrenal surgery” (5 citations) exemplifies his commitment to patient safety in surgical oncology, highlighting rare but critical complications. Beyond his research, Gerke is recognized for his leadership in collaborative science, serving as a principal investigator on major NIH-funded projects and mentoring the next generation of quantitative cancer researchers. His work continues to shape how clinicians and scientists integrate genomic data into personalized cancer care.
Research Focus
Key Achievements
Top Papers
- 1